All
Results: 28285-28296 of 61155

CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union

ProLogium Sets Record-Breaking Standards in Battery Safety and Energy Density Ahead of Schedule with TÜV Rheinland Certification







